vs
德康医疗（DXCM）与RANGE RESOURCES CORP（RRC）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是RANGE RESOURCES CORP的1.6倍（$1.3B vs $786.9M），RANGE RESOURCES CORP净利率更高（22.8% vs 21.2%，领先1.5%），德康医疗同比增速更快（21.6% vs 18.0%），过去两年RANGE RESOURCES CORP的营收复合增速更高（14.6% vs 12.0%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业，核心运营区域为马塞勒斯页岩地层，是该地区拥有土地面积最大的运营商，专注于天然气资源的勘探、开发与生产业务，在北美油气开发领域具备深厚的行业积累。
DXCM vs RRC — 直观对比
营收规模更大
DXCM
是对方的1.6倍
$786.9M
营收增速更快
DXCM
高出3.6%
18.0%
净利率更高
RRC
高出1.5%
21.2%
两年增速更快
RRC
近两年复合增速
12.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $786.9M |
| 净利润 | $267.3M | $179.1M |
| 毛利率 | 62.9% | 94.5% |
| 营业利润率 | 25.6% | — |
| 净利率 | 21.2% | 22.8% |
| 营收同比 | 21.6% | 18.0% |
| 净利润同比 | 153.6% | 88.8% |
| 每股收益（稀释后） | $0.67 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMRRC
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $786.9M | ||
| Q3 25 | $1.2B | $655.3M | ||
| Q2 25 | $1.2B | $699.6M | ||
| Q1 25 | $1.0B | $846.3M | ||
| Q4 24 | $1.1B | $667.0M | ||
| Q3 24 | $994.2M | $567.9M | ||
| Q2 24 | $1.0B | $513.2M |
净利润DXCMRRC
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $179.1M | ||
| Q3 25 | $283.8M | $144.3M | ||
| Q2 25 | $179.8M | $237.6M | ||
| Q1 25 | $105.4M | $97.1M | ||
| Q4 24 | $151.7M | $94.8M | ||
| Q3 24 | $134.6M | $50.7M | ||
| Q2 24 | $143.5M | $28.7M |
毛利率DXCMRRC
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 94.5% | ||
| Q3 25 | 60.5% | 92.5% | ||
| Q2 25 | 59.5% | 95.0% | ||
| Q1 25 | 56.9% | 93.1% | ||
| Q4 24 | 58.9% | 93.7% | ||
| Q3 24 | 59.7% | 94.3% | ||
| Q2 24 | 62.4% | 93.4% |
营业利润率DXCMRRC
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 12.9% | — | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 15.7% | — |
净利率DXCMRRC
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 22.8% | ||
| Q3 25 | 23.5% | 22.0% | ||
| Q2 25 | 15.5% | 34.0% | ||
| Q1 25 | 10.2% | 11.5% | ||
| Q4 24 | 13.6% | 14.2% | ||
| Q3 24 | 13.5% | 8.9% | ||
| Q2 24 | 14.3% | 5.6% |
每股收益（稀释后）DXCMRRC
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.75 | ||
| Q3 25 | $0.70 | $0.60 | ||
| Q2 25 | $0.45 | $0.99 | ||
| Q1 25 | $0.27 | $0.40 | ||
| Q4 24 | $0.37 | $0.38 | ||
| Q3 24 | $0.34 | $0.21 | ||
| Q2 24 | $0.35 | $0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $204.0K |
| 总债务越低越好 | — | $1.2B |
| 股东权益账面价值 | $2.7B | $4.3B |
| 总资产 | $6.3B | $7.4B |
| 负债/权益比越低杠杆越低 | — | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资DXCMRRC
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $204.0K | ||
| Q3 25 | $1.8B | $175.0K | ||
| Q2 25 | $1.2B | $134.0K | ||
| Q1 25 | $904.9M | $344.6M | ||
| Q4 24 | $606.1M | $304.5M | ||
| Q3 24 | $621.2M | $277.4M | ||
| Q2 24 | $939.2M | $251.1M |
总债务DXCMRRC
| Q1 26 | — | — | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B |
股东权益DXCMRRC
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $4.3B | ||
| Q3 25 | $2.7B | $4.2B | ||
| Q2 25 | $2.6B | $4.1B | ||
| Q1 25 | $2.3B | $3.9B | ||
| Q4 24 | $2.1B | $3.9B | ||
| Q3 24 | $2.0B | $3.9B | ||
| Q2 24 | $2.4B | $3.9B |
总资产DXCMRRC
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $7.4B | ||
| Q3 25 | $7.5B | $7.2B | ||
| Q2 25 | $7.3B | $7.1B | ||
| Q1 25 | $6.8B | $7.4B | ||
| Q4 24 | $6.5B | $7.3B | ||
| Q3 24 | $6.4B | $7.2B | ||
| Q2 24 | $6.8B | $7.3B |
负债/权益比DXCMRRC
| Q1 26 | — | — | ||
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $257.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 1.44× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DXCMRRC
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $257.5M | ||
| Q3 25 | $659.9M | $247.5M | ||
| Q2 25 | $303.0M | $336.2M | ||
| Q1 25 | $183.8M | $330.1M | ||
| Q4 24 | $301.4M | $217.9M | ||
| Q3 24 | $199.5M | $245.9M | ||
| Q2 24 | $279.4M | $148.8M |
自由现金流DXCMRRC
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | — | ||
| Q3 25 | $579.4M | — | ||
| Q2 25 | $208.9M | — | ||
| Q1 25 | $96.8M | — | ||
| Q4 24 | $176.8M | — | ||
| Q3 24 | $88.3M | — | ||
| Q2 24 | $213.3M | — |
自由现金流率DXCMRRC
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | — | ||
| Q3 25 | 47.9% | — | ||
| Q2 25 | 18.1% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 15.9% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 21.2% | — |
资本支出强度DXCMRRC
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 8.4% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 6.6% | — |
现金转化率DXCMRRC
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.44× | ||
| Q3 25 | 2.33× | 1.72× | ||
| Q2 25 | 1.69× | 1.42× | ||
| Q1 25 | 1.74× | 3.40× | ||
| Q4 24 | 1.99× | 2.30× | ||
| Q3 24 | 1.48× | 4.85× | ||
| Q2 24 | 1.95× | 5.18× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
